reviewNature reviews. CancerAug 23, 2016Closed access

Engineered T cells: the promise and challenges of cancer immunotherapy

ADAndrew D. FesnakCHCarl H. JuneBLBruce L. Levine

University of Pennsylvania

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,058
total citations
FWCI
66.97
Percentile
100%
References
253
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Chimeric antigen receptor
  • Immune system
  • Adoptive cell transfer
  • Cell therapy
  • Immunotherapy
  • Cancer
  • Cancer research
  • Immunology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding